NO993548L - Anvendelse av <beta>3-adrenergiske reseptoragonister for fremstilling av legende medikamenter - Google Patents

Anvendelse av <beta>3-adrenergiske reseptoragonister for fremstilling av legende medikamenter

Info

Publication number
NO993548L
NO993548L NO993548A NO993548A NO993548L NO 993548 L NO993548 L NO 993548L NO 993548 A NO993548 A NO 993548A NO 993548 A NO993548 A NO 993548A NO 993548 L NO993548 L NO 993548L
Authority
NO
Norway
Prior art keywords
beta
preparation
receptor agonists
adrenergic receptor
healing drugs
Prior art date
Application number
NO993548A
Other languages
English (en)
Other versions
NO326823B1 (no
NO993548D0 (no
Inventor
Andre Bernat
Jean-Marc Herbert
Michele Arnone
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO993548L publication Critical patent/NO993548L/no
Publication of NO993548D0 publication Critical patent/NO993548D0/no
Publication of NO326823B1 publication Critical patent/NO326823B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
NO19993548A 1997-01-21 1999-07-20 Anvendelse av β3-adrenergiske reseptoragonister for fremstilling av legende medikamenter NO326823B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700584A FR2758460B1 (fr) 1997-01-21 1997-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
PCT/FR1998/000105 WO1998031357A1 (fr) 1997-01-21 1998-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants

Publications (3)

Publication Number Publication Date
NO993548L true NO993548L (no) 1999-07-20
NO993548D0 NO993548D0 (no) 1999-07-20
NO326823B1 NO326823B1 (no) 2009-02-23

Family

ID=9502810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993548A NO326823B1 (no) 1997-01-21 1999-07-20 Anvendelse av β3-adrenergiske reseptoragonister for fremstilling av legende medikamenter

Country Status (15)

Country Link
US (1) US6235793B1 (no)
EP (1) EP0966276B1 (no)
JP (1) JP2001508790A (no)
AR (1) AR011546A1 (no)
AT (1) ATE255889T1 (no)
AU (1) AU5994198A (no)
BR (1) BR9807288A (no)
CA (1) CA2278220A1 (no)
DE (1) DE69820422T2 (no)
FR (1) FR2758460B1 (no)
HR (1) HRP980023A2 (no)
NO (1) NO326823B1 (no)
UY (1) UY24848A1 (no)
WO (1) WO1998031357A1 (no)
ZA (1) ZA98484B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
WO2003106423A1 (ja) * 2002-06-12 2003-12-24 住友製薬株式会社 環状アミン類およびそれを含む医薬組成物
WO2008077410A1 (en) 2006-12-22 2008-07-03 Nkt Flexibles I/S A flexible pipe
WO2008077409A1 (en) 2006-12-22 2008-07-03 Nkt Flexibles I/S A flexible pipe
AU2022221588A1 (en) * 2021-02-22 2023-09-07 Northern Sydney Local Health District Wound healing methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029320B1 (en) * 1979-11-15 1985-07-10 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
US5597843A (en) 1995-06-07 1997-01-28 Houghten Pharmaceuticals Use of a substituted 1,3-benzodioxole to reduce a wasting condition
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs

Also Published As

Publication number Publication date
ZA98484B (en) 1998-07-30
DE69820422D1 (de) 2004-01-22
JP2001508790A (ja) 2001-07-03
WO1998031357A1 (fr) 1998-07-23
BR9807288A (pt) 2000-03-21
AU5994198A (en) 1998-08-07
UY24848A1 (es) 1998-04-21
HRP980023A2 (en) 1998-10-31
EP0966276A1 (fr) 1999-12-29
AR011546A1 (es) 2000-08-30
FR2758460A1 (fr) 1998-07-24
EP0966276B1 (fr) 2003-12-10
NO326823B1 (no) 2009-02-23
ATE255889T1 (de) 2003-12-15
FR2758460B1 (fr) 1999-12-31
US6235793B1 (en) 2001-05-22
DE69820422T2 (de) 2004-10-28
CA2278220A1 (en) 1998-07-23
NO993548D0 (no) 1999-07-20

Similar Documents

Publication Publication Date Title
ZA98691B (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
NO20022105D0 (no) Positive modulatorer av nikotinreseptoragonister
NO20006220L (no) &lt;beta&gt;2-adrenergistiske reseptoragonister
PT1189916E (pt) N-pirazole agonistas do receptor a2a
NO995753D0 (no) Gastroretarderende mikrosfaerer med styrt frigivelse for bedret administrasjon av medikament
HUP0203681A3 (en) Pharmaceutical compositions containing agonists specific for the peripheral cannabinoid receptor and their use
AU7667300A (en) Use of central cannabinoid receptor antagonist for preparing medicines
EE04499B1 (et) A1-adenosiiniretseptori agonistid, nende valmistamismeetod ja kasutamine
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
IS5245A (is) Lyfjablanda úr ómeprasól
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO996372D0 (no) Fast farmasoeytisk preparat inneholdende benzofuanderivater
EE200000319A (et) hGRF-PEG konjugaatide saitspetsiifiline valmistamismeetod, hGRF-PEG konjugaadid, nende vaheühendid, kasutamine ja farmatseutiline kompositsioon
NO992667L (no) Ny human &lt;beta&gt;2-integrin-&lt;alfa&gt;-subenhet
NO307049B1 (no) Forbindelse som er &lt;Beta&gt;-adrenergiske agonister, anvendelse derav og farmasøytisk blanding
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
HUP9900501A3 (en) Oxa- and thia-diazole derivatives as muscarinic receptor antagonists, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
IL127947A0 (en) Pharmaceutical use of adenosine agonists
NO993548L (no) Anvendelse av &lt;beta&gt;3-adrenergiske reseptoragonister for fremstilling av legende medikamenter
DK1001962T3 (da) Fremstilling af avermectinforbindelser
NO995821L (no) Anvendelse av 4-substituerte tetrahydropyridiner for fremstilling av medisiner som virker på TGF-&lt;beta&gt;1

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees